Unspecified nephritic syndrome with diffuse membranous glomerulonephritis
ICD-10 N05.2 is a billable code used to indicate a diagnosis of unspecified nephritic syndrome with diffuse membranous glomerulonephritis.
Unspecified nephritic syndrome with diffuse membranous glomerulonephritis is characterized by the presence of nephritic syndrome symptoms, including hematuria, proteinuria, and hypertension, alongside the histological findings of diffuse membranous glomerulonephritis. This condition results from the immune-mediated damage to the glomerular capillary walls, leading to increased permeability and subsequent protein leakage into the urine. Patients typically present with edema, oliguria, and signs of renal impairment. Diagnosis is often confirmed through renal biopsy, which reveals diffuse thickening of the glomerular capillary walls due to subepithelial immune complex deposition. Management may involve corticosteroids, immunosuppressive agents, and supportive care, including blood pressure control and diuretics for edema. The prognosis varies, with some patients achieving remission while others may progress to chronic kidney disease.
Detailed clinical notes on symptoms, laboratory findings, and renal biopsy results.
Patients presenting with edema, hypertension, and abnormal urinalysis findings.
Ensure clear documentation of the type of glomerulonephritis and treatment plans.
Comprehensive reports on renal biopsy findings, including histological analysis.
Evaluation of renal biopsies for suspected glomerular diseases.
Accurate description of glomerular changes is crucial for proper coding.
When a renal biopsy is performed to confirm the diagnosis of nephritic syndrome.
Documentation of indications for biopsy and results.
Nephrologists must ensure that the biopsy findings correlate with the clinical diagnosis.
Nephritic syndrome is characterized by hematuria, proteinuria, and hypertension, while nephrotic syndrome is defined by significant proteinuria, hypoalbuminemia, and edema without hematuria.
